BSX Entangled in Patent Issues - Analyst Blog
22 Mai 2013 - 9:45PM
Zacks
Medical technology major
Boston Scientific Corporation (BSX) was hit by
another patent tiff when Germany-based OrbusNeich Medical Inc. and
its subsidiary, OrbusNeich Medical GmbH enforced the seizure of
more than 190 stent systems from the company.
The latest dispute challenging Boston Scientific is associated with
the patent infringement proceedings against the company in the
Dusseldorf Regional Court. According to OrbusNeich, Boston
Scientific violated the preliminary injunction of the Court which
prohibits it from marketing and selling certain line of stents in
Germany.
The affected stent lines include Small Vessel, Small Workhorse and
Workhorse Stents under the company’s PROMUS Element, PROMUS Element
Plus, OMEGA, TAXUS Element, SYNERGY and Promus PREMIER portfolio.
According to the Court’s Apr 30, 2013 ruling, the geometric pattern
of these affected stent lines infringe OrbusNeich’s patent
EP1341482.
The stent systems were found at the premises of Boston Scientific’s
German subsidiary Boston Scientific Medizintechnik GmbH in Ratingen
on May 15. OrbusNeich has filed parallel patent infringement
lawsuits in The Netherlands and Ireland. OrbusNeich is also seeking
more definitive action in the form of a permanent injunction and
damages.
Last week, Boston Scientific received a patent infringement
complaint from Vascular Solutions Inc. (VASC), a
provider of medical devices for coronary and peripheral vascular
procedures. Vascular Solutions has filed the complaint in the U.S.
District Court for the District of Minnesota.
According to Vascular Solutions, Boston Scientific infringed three
patents owned by it. The complaint alleges, among other things,
that the production and sale of Guidezilla guide extension catheter
by Boston Scientific, which gained the 510(k) clearance from the
U.S. Food and Drug Administration (FDA) in Mar 2013, infringes the
patent landscape of Vascular Solutions’ GuideLiner catheter.
Amid several patent issues, Boston Scientific carries a Zacks Rank
#3 (Hold). Other medical sector stocks that warrant a look are
Conceptus Inc. (CPTS) carrying a Zacks Rank #1
(Strong Buy) and Becton Dickinson and Company
(BDX), carrying a Zacks Rank #2 (Buy).
BECTON DICKINSO (BDX): Free Stock Analysis Report
BOSTON SCIENTIF (BSX): Free Stock Analysis Report
CONCEPTUS INC (CPTS): Free Stock Analysis Report
VASCULAR SOLUTN (VASC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Conceptus, Inc. (MM) (NASDAQ:CPTS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Conceptus, Inc. (MM) (NASDAQ:CPTS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Conceptus, Inc. (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Conceptus, Inc. (MM)